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  There are many cases of advanced renal cell carcinoma refractory to chemotherapy with cytotoxic
agents and／or hormonal drugs・Adriamycin， an an亡hracyclfne antitumor agcnt， has wide spectrum
of antitumor activities． After injected， adriamycin disappears from blood in a short time and it is
absorbed and accumulated into organs． According to these characteristics， it is suggested that adria－
mycin is one of the most suitable drug for intraarterial infusiop therapy．
  This paper reports a case of renal cell carcinoma refractory to the chemotherapy with Provera，
mitomycin C， 5－fluorDuracil and cyclophosphamide in combination， who was treated with adriamycin
（total dose of400 mg） by intraarterial infusion．
  The good response to adriamycin was demonstrated in both primary’and metastatic tumors， but
the patient died due to renal insufficiency after 3 months remission．
  In the postmortem study， it一 was found that the renal tumor was replaced mostly with scar tissue，
in which a few non－viable tumor cells were found in making small nests． Since degenerated renal
nephrons due to adriamycin waB not fDund， it waS thought that renal dysfunction was caused by a
large scared tumor mass pressing the renal collecting systems and blood supplies．







































2 ％， Eo 2 ％， St 6 ％， II 33％， III 28．0／o， IV 8 2／o，
Ly 21％ Mo O％
 Jfll清酵素活性， LDH 365 mutmlと軽度上昇を示す
以外に著変はない．血清総蛋白7．79／d1， AIG比0．88，










Fig． 1． Histopathologicalfindings of metastatic tumor． A） Clear
    cell type tumor cells showing medullary proliferation
    were observed in low magnification， B） Tumor cells in

































日目． ， 川 川 川
WBC 8，500 7，400 2，600 7，000 6，300



















Table 1． Postmoten final diagnosis．
 Right renal cell carcinoma， clear cell type， with hyallnized
 stromol prollferation
2． Left renal tubercu［osis
5． Uremic change in organs C serosMs， hemorrhaglc tendency）




8． Systemlc congestion of the orgons
9． Anernic infarction of sp［een
lO． Retroperitonltis due to theropeutic side eftect
工mmediate couSe Of death：RenOl dysfun⊂tion due to renal









































Right renal arteriograms． A） Typical tumor stain or pooling and colateral
venous flow were observed before medication． B） Marked tumor stain
disappeared after administration of 160 mg of adriamycin． C） Renal arte－
riogram after administration of 280 mg of adriamycin． D） After the medi－
cation with 400 mg of adriamycin， tumor stain or pooling was not found
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Fig． 4． Chest X－ray films． A） Before the medication with adriamycin．
    administration of 160 mg of adriamycin． C） Two months
    medication with 400 mg of adriamycin． D） Three months




































Fig．5． Pathological findings of right kidny removed at autopsy．
   A） On cut－surface yellow－whitish elastic tumor infiltrating
   to renal parenchyma was observed． B） On histopathological
   finding， non－viable tumor cells making small nest surrounded
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